Clinical Trial

Building Cognitive Resilience to Vaccine Misinformation Using AI in Europe

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This multi-country trial evaluates an AI chatbot designed to counter cognitive biases and inoculate parents against vaccine misinformation, embedded within a large survey across five European countries (n=5,000). Scaled from a 2026 single-country study, outcomes compare behavioural and attitudinal responses against standard-of-care materials (e.g., UNICEF infographics) to identify effective, scalable misinformation interventions.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-20.
Trial Details
NCT Number NCT07551986
Lead Sponsor London School of Hygiene and Tropical Medicine
Conditions Healthy
Enrollment 5,000 participants
Start Date 2026-04
Primary Completion 2026-04 (estimated)
Study Completion 2026-04 (estimated)
Updated on ClinicalTrials.gov 2026-05-01